Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo.

Murrough JW, Huryk KM, Mao X, Iacoviello B, Collins K, Nierenberg AA, Kang G, Shungu DC, Iosifescu DV.

J Affect Disord. 2018 Apr 1;230:56-64. doi: 10.1016/j.jad.2017.12.067. Epub 2018 Jan 2.

PMID:
29407539
2.

A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder.

Sayed S, Van Dam NT, Horn SR, Kautz MM, Parides M, Costi S, Collins KA, Iacoviello B, Iosifescu DV, Mathé AA, Southwick SM, Feder A, Charney DS, Murrough JW.

Int J Neuropsychopharmacol. 2018 Jan 1;21(1):3-11. doi: 10.1093/ijnp/pyx109.

3.

Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).

Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, Papakostas GI.

Brain Stimul. 2018 Jan - Feb;11(1):75-84. doi: 10.1016/j.brs.2017.09.010. Epub 2017 Sep 23.

PMID:
29030111
4.

A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy.

Richards C, Iosifescu DV, Mago R, Sarkis E, Reynolds J, Geibel B, Dauphin M.

J Psychopharmacol. 2017 Sep;31(9):1190-1203. doi: 10.1177/0269881117722998. Epub 2017 Aug 31.

5.

Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial.

Murrough JW, Wade E, Sayed S, Ahle G, Kiraly DD, Welch A, Collins KA, Soleimani L, Iosifescu DV, Charney DS.

J Affect Disord. 2017 Aug 15;218:277-283. doi: 10.1016/j.jad.2017.04.072. Epub 2017 Apr 29.

PMID:
28478356
6.

Ketamine and ECT: better alone than together?

Kellner CH, Iosifescu DV.

Lancet Psychiatry. 2017 May;4(5):348-349. doi: 10.1016/S2215-0366(17)30099-8. Epub 2017 Mar 27. No abstract available.

7.

Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.

Kiraly DD, Horn SR, Van Dam NT, Costi S, Schwartz J, Kim-Schulze S, Patel M, Hodes GE, Russo SJ, Merad M, Iosifescu DV, Charney DS, Murrough JW.

Transl Psychiatry. 2017 Mar 21;7(3):e1065. doi: 10.1038/tp.2017.31.

8.

The influence of depression on personality traits in patients with fibromyalgia: a case-control study.

Santos DM, Lage LV, Jabur EK, Kaziyama HHS, Iosifescu DV, De Lucia MCS, Fráguas R.

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):13-19. Epub 2016 Oct 20.

PMID:
27782872
9.

Ketamine Treatment and Global Brain Connectivity in Major Depression.

Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, DeWilde KE, Wong E, Anticevic A, Tang CY, Iosifescu DV, Charney DS, Murrough JW.

Neuropsychopharmacology. 2017 May;42(6):1210-1219. doi: 10.1038/npp.2016.186. Epub 2016 Sep 8.

10.

The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy.

Iosifescu DV, Neborsky RJ, Valuck RJ.

Neuropsychiatr Dis Treat. 2016 Aug 25;12:2131-42. doi: 10.2147/NDT.S113712. eCollection 2016.

11.

Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression.

Harper DG, Jensen JE, Ravichandran C, Perlis RH, Fava M, Renshaw PF, Iosifescu DV.

Neuropsychopharmacology. 2017 Mar;42(4):876-885. doi: 10.1038/npp.2016.180. Epub 2016 Sep 2.

12.

Using Electroencephalography for Treatment Guidance in Major Depressive Disorder.

Wade EC, Iosifescu DV.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Sep;1(5):411-422. doi: 10.1016/j.bpsc.2016.06.002. Epub 2016 Jun 9. Review.

PMID:
29560870
13.

Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder.

Murrough JW, Abdallah CG, Anticevic A, Collins KA, Geha P, Averill LA, Schwartz J, DeWilde KE, Averill C, Jia-Wei Yang G, Wong E, Tang CY, Krystal JH, Iosifescu DV, Charney DS.

Hum Brain Mapp. 2016 Sep;37(9):3214-23. doi: 10.1002/hbm.23235. Epub 2016 May 4.

14.

White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.

Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA.

Aust N Z J Psychiatry. 2017 Apr;51(4):355-365. doi: 10.1177/0004867416644508. Epub 2016 Jul 11.

PMID:
27126391
15.

Ketamine for treatment-resistant depression: recent developments and clinical applications.

Schwartz J, Murrough JW, Iosifescu DV.

Evid Based Ment Health. 2016 May;19(2):35-8. doi: 10.1136/eb-2016-102355. Epub 2016 Apr 6. Review.

PMID:
27053196
16.

Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis.

Cassano P, Petrie SR, Hamblin MR, Henderson TA, Iosifescu DV.

Neurophotonics. 2016 Jul;3(3):031404. doi: 10.1117/1.NPh.3.3.031404. Epub 2016 Mar 4. Review.

17.

A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).

Ostacher MJ, Nierenberg AA, Rabideau D, Reilly-Harrington NA, Sylvia LG, Gold AK, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Iosifescu DV, Thase ME, Leon AC, Trivedi MH.

J Psychiatr Res. 2015 Dec;71:126-33. doi: 10.1016/j.jpsychires.2015.10.004. Epub 2015 Oct 9.

PMID:
26476489
18.

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study.

Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV.

Psychiatry J. 2015;2015:352979. doi: 10.1155/2015/352979. Epub 2015 Aug 19.

19.

Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.

Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, Iosifescu DV, Charney DS.

Psychol Med. 2015 Dec;45(16):3571-80. doi: 10.1017/S0033291715001506. Epub 2015 Aug 12.

PMID:
26266877
20.

Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.

Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, O'Reardon JP, Gilmer WS, Jain R, Burgoyne KS, Phillips B, Manberg PJ, Massaro J, Hunter AM, Lisanby SH, George MS.

Brain Stimul. 2015 Jul-Aug;8(4):787-94. doi: 10.1016/j.brs.2015.05.005. Epub 2015 May 22.

PMID:
26143022

Supplemental Content

Loading ...
Support Center